USFDA closes warning letter for three sites of Dr. Reddy's Laboratories

28 Aug 2020 Evaluate

The US health regulator has a closed warning letter issued for three sites of Dr. Reddy's Laboratories in Andhra Pradesh and Telangana, following evaluation of corrective actions taken by the company.

In November 2015, it had received a warning letter from the US Food and Drug Administration (USFDA) for three of its sites -- active pharmaceutical ingredient (API) manufacturing facilities at Srikakulam, Andhra Pradesh, and Miryalguda, Telangana, and Oncology formulation manufacturing facility at Duvadda, Visakhapatnam, Andhra Pradesh.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1246.25 -20.90 (-1.65%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×